Paper24948870
Targeting androgen receptor action for prostate cancer treatment: does the post-receptor level provide novel opportunities?
Heemers HV. Int J Biol Sci, 2014. Cited by 15 papers, by iCite.
Cite this record
ConductScience Library. Targeting androgen receptor action for prostate cancer treatment: does the post-receptor level provide novel opportunities? Papers, record 24948870. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24948870
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Targeting androgen receptor action for prostate cancer treatment: does the post-receptor level provide novel opportunities?
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Prostatic Neoplasms | Major topic |
| Receptors, Androgen | Major topic |
| Gene Expression Regulation, Neoplastic | |
| Humans | |
| Male | |
| Signal Transduction |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P30 CA016056 | NCI NIH HHS | United States | P30CA016056 | PubMed and NIH | NIH RePORTER |
| R01 CA166440 | NCI NIH HHS | United States | R01CA166440 | PubMed and NIH | NIH RePORTER |
References115
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22411952 | Interactions of abiraterone, eplerenone, and prednisolone with wild-type and mutant androgen receptor: a rationale for increasing abiraterone exposure or combining with MDV3100. | Cancer Res | 2012 | https://conductscience.org/library/papers/22411952 | PubMed |
| 2 | 22402316 | Androgen action in the prostate gland. | Minerva Urol Nefrol | 2012 | https://conductscience.org/library/papers/22402316 | PubMed |
| 3 | 22249003 | Orteronel (TAK-700), a novel non-steroidal 17,20-lyase inhibitor: effects on steroid synthesis in human and monkey adrenal cells and serum steroid levels in cynomolgus monkeys. | J Steroid Biochem Mol Biol | 2012 | https://conductscience.org/library/papers/22249003 | PubMed |
| 4 | 12775722 | Differential requirement of SWI/SNF for androgen receptor activity. | J Biol Chem | 2003 | https://conductscience.org/library/papers/12775722 | PubMed |
| 5 | 23228172 | Abiraterone in metastatic prostate cancer without previous chemotherapy. | N Engl J Med | 2013 | https://conductscience.org/library/papers/23228172 | PubMed |
| 6 | 19363526 | Microarray coupled to quantitative RT-PCR analysis of androgen-regulated genes in human LNCaP prostate cancer cells. | Oncogene | 2009 | https://conductscience.org/library/papers/19363526 | PubMed |
| 7 | 21807635 | Resistance to CYP17A1 inhibition with abiraterone in castration-resistant prostate cancer: induction of steroidogenesis and androgen receptor splice variants. | Clin Cancer Res | 2011 | https://conductscience.org/library/papers/21807635 | PubMed |
| 8 | 17986282 | Novel 5 alpha-steroid reductase (SRD5A3, type-3) is overexpressed in hormone-refractory prostate cancer. | Cancer Sci | 2008 | https://conductscience.org/library/papers/17986282 | PubMed |
| 9 | 16510604 | Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer. | Cancer Res | 2006 | https://conductscience.org/library/papers/16510604 | PubMed |
| 10 | 15663990 | Androgens, lipogenesis and prostate cancer. | J Steroid Biochem Mol Biol | 2004 | https://conductscience.org/library/papers/15663990 | PubMed |
| 11 | 10223244 | Allelic imbalance in the clonal evolution of prostate carcinoma. | Cancer | 1999 | https://conductscience.org/library/papers/10223244 | PubMed |
| 12 | 19632176 | Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer. | Cell | 2009 | https://conductscience.org/library/papers/19632176 | PubMed |
| 13 | 3353726 | Molecular cloning of human and rat complementary DNA encoding androgen receptors. | Science | 1988 | https://conductscience.org/library/papers/3353726 | PubMed |
| 14 | 21796522 | Identification and characterization of androgen response elements. | Methods Mol Biol | 2011 | https://conductscience.org/library/papers/21796522 | PubMed |
| 15 | 24002508 | Phase I study of ARN-509, a novel antiandrogen, in the treatment of castration-resistant prostate cancer. | J Clin Oncol | 2013 | https://conductscience.org/library/papers/24002508 | PubMed |
| 16 | 21303972 | Activation of the androgen receptor by intratumoral bioconversion of androstanediol to dihydrotestosterone in prostate cancer. | Cancer Res | 2011 | https://conductscience.org/library/papers/21303972 | PubMed |
| 17 | 16518832 | Molecular regulation of androgen action in prostate cancer. | J Cell Biochem | 2006 | https://conductscience.org/library/papers/16518832 | PubMed |
| 18 | 18997859 | Genomic androgen receptor-occupied regions with different functions, defined by histone acetylation, coregulators and transcriptional capacity. | PLoS One | 2008 | https://conductscience.org/library/papers/18997859 | PubMed |
| 19 | 17173048 | Integrative molecular concept modeling of prostate cancer progression. | Nat Genet | 2007 | https://conductscience.org/library/papers/17173048 | PubMed |
| 20 | 20304998 | The rules of DNA recognition by the androgen receptor. | Mol Endocrinol | 2010 | https://conductscience.org/library/papers/20304998 | PubMed |
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36611918 | The SMARCD Family of SWI/SNF Accessory Proteins Is Involved in the Transcriptional Regulation of Androgen Receptor-Driven Genes and Plays a Role in Various Essential Processes of Prostate Cancer. | Cells | 2022 | https://conductscience.org/library/papers/36611918 | PubMed |
| 36597514 | Prostate Cancer Disparities and Management in Southern Africa: Insights into Practices, Norms and Values. | Cancer Manag Res | 2022 | https://conductscience.org/library/papers/36597514 | PubMed |
| 34503116 | Identification of Androgen Receptor Metabolic Correlome Reveals the Repression of Ceramide Kinase by Androgens. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34503116 | PubMed |
| 33722247 | The inhibitory effect of melatonin on human prostate cancer. | Cell Commun Signal | 2021 | https://conductscience.org/library/papers/33722247 | PubMed |
| 31877956 | Therapies Targeted to Androgen Receptor Signaling Axis in Prostate Cancer: Progress, Challenges, and Hope. | Cancers (Basel) | 2019 | https://conductscience.org/library/papers/31877956 | PubMed |
| 29108267 | Beta-catenin represses protein kinase D1 gene expression by non-canonical pathway through MYC/MAX transcription complex in prostate cancer. | Oncotarget | 2017 | https://conductscience.org/library/papers/29108267 | PubMed |
| 28826481 | A comprehensive analysis of coregulator recruitment, androgen receptor function and gene expression in prostate cancer. | Elife | 2017 | https://conductscience.org/library/papers/28826481 | PubMed |
| 28566530 | Rationale for the development of alternative forms of androgen deprivation therapy. | Endocr Relat Cancer | 2017 | https://conductscience.org/library/papers/28566530 | PubMed |
| 28389515 | Androgen Signaling in Prostate Cancer. | Cold Spring Harb Perspect Med | 2017 | https://conductscience.org/library/papers/28389515 | PubMed |
| 27451135 | Intratumoral and Intertumoral Genomic Heterogeneity of Multifocal Localized Prostate Cancer Impacts Molecular Classifications and Genomic Prognosticators. | Eur Urol | 2017 | https://conductscience.org/library/papers/27451135 | PubMed |
| 27019626 | Therapeutic Rationales, Progresses, Failures, and Future Directions for Advanced Prostate Cancer. | Int J Biol Sci | 2016 | https://conductscience.org/library/papers/27019626 | PubMed |
| 26876983 | Regulators of Androgen Action Resource: a one-stop shop for the comprehensive study of androgen receptor action. | Database (Oxford) | 2016 | https://conductscience.org/library/papers/26876983 | PubMed |
| 25374913 | Revisiting nomenclature for the description of prostate cancer androgen-responsiveness. | Am J Clin Exp Urol | 2014 | https://conductscience.org/library/papers/25374913 | PubMed |
| 24948878 | Biological and clinical significance of androgens and androgen receptor in prostate cancer. | Int J Biol Sci | 2014 | https://conductscience.org/library/papers/24948878 | PubMed |
Genes21
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24948870
GET https://conductscience.org/api/papers/v1/24948870/references?page=2